LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 159 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $8,567,000 | -1.2% | 80,000 | 0.0% | 0.48% | +10.4% |
| Q4 2015 | $8,674,000 | -10.8% | 80,000 | -29.5% | 0.43% | -23.2% |
| Q3 2015 | $9,721,000 | -15.1% | 113,500 | 0.0% | 0.56% | -8.9% |
| Q2 2015 | $11,452,000 | +30.9% | 113,500 | 0.0% | 0.62% | -5.9% |
| Q1 2015 | $8,752,000 | +9.9% | 113,500 | -24.2% | 0.66% | -24.2% |
| Q4 2014 | $7,966,000 | +13.2% | 149,700 | 0.0% | 0.87% | -11.5% |
| Q3 2014 | $7,034,000 | -24.6% | 149,700 | 0.0% | 0.98% | -22.6% |
| Q2 2014 | $9,325,000 | -6.3% | 149,700 | +1.2% | 1.27% | -17.9% |
| Q1 2014 | $9,948,000 | +40.7% | 147,900 | +10.0% | 1.54% | -29.1% |
| Q4 2013 | $7,069,000 | – | 134,400 | – | 2.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |